Compassionate use programme for treatment of Crohn's disease with QBECO.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 28 Jul 2015
At a glance
- Drugs QBECO (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Expanded access; Therapeutic Use
- Sponsors Qu Biologics
- 28 Jul 2015 Results published in Qu Biologics media release.
- 03 Nov 2014 New trial record
- 29 Oct 2014 Results published in a Qu Biologics media release.